NEU neuren pharmaceuticals limited

Share Price, page-13665

  1. 36 Posts.
    lightbulb Created with Sketch. 126
    JPow, I would normally not respond to such a negative post such was yours telling me "I have my hand on it". But your constant negativity leaves me no choice.
    I have held multiple roles as CFO of ASX Listed organisations. These have all had buy backs at some stage. When a company commits to a buy back it does not decide to turn it off whilst the share price is below its target. The current NEU share price is below its target. However, it must turn it off when the company has confidential information which the market does not.
    I refer you to ASX Listing rule 3.1.
    A company must disclose market sensitive information, under its continuous disclosure obligations, immediately to the market, save for 5 explicit carve outs. It's dot point 2 in those carve outs (under 3.1A.1) which I suggest you read closely;
    ○ The information concerns and incomplete proposals or negotiation
    Therefore, in my opinion, this is the current status within NEU. I may be wrong, so suggest everyone does their own and proper research.
    Back to your assertion that I have my hand on it. I'm happy to meet you anytime at the Steyne Hotel in Manly to "discuss"......but your wouldn't turn up.....because your keyboard is a safe place and the Steyne may not be that....
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$18.18
Change
1.170(6.88%)
Mkt cap ! $2.274B
Open High Low Value Volume
$17.48 $18.44 $17.48 $7.833M 435.5K

Buyers (Bids)

No. Vol. Price($)
5 357 $18.16
 

Sellers (Offers)

Price($) Vol. No.
$18.18 577 4
View Market Depth
Last trade - 11.25am 07/08/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.